ABTD
DXCM icon

Arvest Bank Trust Division’s DexCom DXCM Stock Holding History

Arvest Bank Trust Division’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.71M Buy
+59,127
New +$4.12M 0.2% 73

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arvest Bank Trust Division's DXCM Position: Q1 2026 in Review

Arvest Bank Trust Division opened a new position in DexCom (DXCM) in Q1 2026: 59,127 shares worth $3.71M. The stake represents 0.2% of the portfolio and ranks #73 among its holdings.

959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Arvest Bank Trust Division held 59,127 shares of DexCom worth $3.71M as of Q1 2026.
  • DexCom was a new Arvest Bank Trust Division position in Q1 2026.
  • DexCom made up 0.2% of Arvest Bank Trust Division's portfolio in Q1 2026, its #73 holding.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Arvest Bank Trust Division's 13F filing for Q1 2026, filed 13 May 2026.